Monday, December 05, 2016
 
 
Video: Page (1) of 1 - 12/20/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Cancer Drug Partnerships: Immunogen to Collaborate with Lilly, Amgen Partners with Watson

By DMO Affiliate
ImmunoGen (IMGN) said today it has entered a collaboration agreement with Eli Lilly (LLY) under which Lilly will pay $20 million for rights to a limited number of exclusive licenses to use ImmunoGen's maytansinoid Targeted Antibody Payload technology with
Cancer Drug Partnerships: Immunogen to Collaborate with Lilly, Amgen Partners with Watson




Page: 1


null
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines